Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Selective GlyT2 inhibitor shows promising analgesic effects in vivo

Jan. 3, 2012

Takeda identifies benzazepine derivatives for treatment of obesity

Jan. 3, 2012

Toray divulges new inhibitors of 11-beta-HSD1

Jan. 2, 2012

Astellas Pharma presents new drug for treatment of transplant rejection

Jan. 2, 2012

Findings presented from two phase III trials of Lu-AA-21004 in GAD

Jan. 2, 2012

Study evaluates repeated daily oxytocin as a therapy for anxiety

Dec. 30, 2011

Dengue virus vaccine assessed in healthy volunteers

Dec. 30, 2011

Phase III BTOG2 trial assesses combination therapies for advanced lung cancer

Dec. 30, 2011

U.K. study uncovers new putative biomarker of pulmonary arterial hypertension

Dec. 29, 2011

Clinical studies assess prasugrel in sickle cell disease

Dec. 29, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...